FIELD: medicine. SUBSTANCE: method involves supplying blood or artificial blood substitute agent into arterial blood vessel in pulsating mode at helical trajectory and removing the mentioned blood or artificial blood substitute agent from venous blood vessels. The device has blood or artificial blood substitute agent supply means operating in pulsating mode, means for saturating blood or artificial blood substitute agent with oxygen, reservoir, means for connecting the device to venous blood vessels, and means for connecting the device to arterial blood vessel manufactured in a way that blood or artificial blood substitute agent come to the mentioned arterial blood vessel in helical flow mode. EFFECT: enhanced effectiveness in reproducing natural physiological blood circulation motion. 9 cl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
VASCULAR CANNULA | 2002 |
|
RU2233632C1 |
METHOD OF EXTRACORPORAL RECOVERY OF PERFUSION AND OXYGENATION IN DONOR BODY | 2017 |
|
RU2666515C2 |
METHOD OF CARDIOPULMONARY BYPASS IN CARDIAC TRANSPLANT RECIPIENT DURING ITS TRANSPLANTATION AND SYSTEM FOR ITS IMPLEMENTATION | 2024 |
|
RU2826522C1 |
0 |
|
SU135597A1 | |
ARTIFICIAL CIRCULATION METHOD AND DEVICE FOR ITS IMPLEMENTATION | 2016 |
|
RU2633947C1 |
METHOD FOR RESTORATION AND MAINTENANCE OF VITALITY OF AN ISCHEMICALLY DAMAGED DONOR ORGAN | 2010 |
|
RU2441608C1 |
METHOD FOR PREVENTING REPERFUSION MYOCARDIAL DAMAGE IN CONGENITAL HEART DISEASE SURGERY | 2019 |
|
RU2718308C1 |
SYSTEM AND METHOD OF CIRCULATORY SUPPORT DURING LIVER SURGERY | 2023 |
|
RU2812592C1 |
METHOD OF HAEMODYNAMIC SUPPORT AND PROTECTION OF MYOCARDIUM IN ENDOVASCULAR CORONARY REVASCULARISATION IN HIGH-RISK PATIENTS | 2012 |
|
RU2479250C1 |
DEVICE FOR EXTRACORPOREAL MECHANICAL PERFUSION OF DONOR ORGANS INSIDE DONOR'S BODY | 2014 |
|
RU2570391C1 |
Authors
Dates
2004-03-27—Published
2002-06-03—Filed